The Correlation Between Compliance with Iron Supplement Tablet Consumption and Anemia Among Pregnant Women at Puskesmas Kalibagor

Abstract

Anemia remains one of the leading causes of maternal mortality in 2023. One of the strategies implemented to reduce maternal mortality is the provision of iron supplement tablets to prevent anemia during pregnancy, which is associated with increased risks of preterm birth, maternal and neonatal death, and susceptibility to infections. The purpose of this study to examine the relationship between compliance with iron supplement tablet consumption and the incidence of anemia in pregnant women at Puskesmas (Community Healthcare Center) Kalibagor. Methods:This study employed a quantitative approach using a cross-sectional design. Data collection was conducted through interviews using structured questionnaires with third-trimester pregnant women. The majority of respondents were of low-risk maternal age, nulliparous, not experiencing chronic energy deficiency (CED), had a moderate level of education, were compliant with iron tablet consumption, and were not anemic. Bivariate analysis of the correlation between compliance and anemia incidence among 36 third-trimester pregnant women yielded a p-value of 0.863 and a correlation coefficient (rho) of -0.030. These results indicate no significant correlation between compliance with iron supplement consumption and the incidence of anemia, with a very weak negative correlation, suggesting that lower compliance may be associated with a higher risk of anemia.